Harvey Risch, Robert W. Malone, and Byram Bridle
Contributor
Dr. Harvey Risch is professor of epidemiology at the Yale School of Public Health, Yale School of Medicine, and Yale Cancer Center. He published the seminal paper on early treatment of high-risk COVID-19 outpatients in the American Journal of Epidemiology and gave testimony about early COVID-19 treatment before the U.S. Senate in November 2020. Dr. Robert W. Malone is a pioneer of mRNA technology and authored groundbreaking research on how RNA could be delivered into cells. Dr. Byram Bridle is an associate professor of viral immunology at the University of Guelph in Canada, whose research team studies the body’s immune response to viruses and develops vaccines to prevent infectious diseases and immunotherapies to treat cancers.
